<SEC-DOCUMENT>0001493152-18-016244-index.html : 20181115
<SEC-HEADER>0001493152-18-016244.hdr.sgml : 20181115
<ACCEPTANCE-DATETIME>20181115103914
ACCESSION NUMBER:		0001493152-18-016244
CONFORMED SUBMISSION TYPE:	NT 10-Q
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20180930
FILED AS OF DATE:		20181115
DATE AS OF CHANGE:		20181115
EFFECTIVENESS DATE:		20181115

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Adhera Therapeutics, Inc.
		CENTRAL INDEX KEY:			0000737207
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				112658569
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		NT 10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-13789
		FILM NUMBER:		181186256

	BUSINESS ADDRESS:	
		STREET 1:		4721 EMPEROR BOULEVARD
		STREET 2:		SUITE 350
		CITY:			DURHAM
		STATE:			NC
		ZIP:			27703
		BUSINESS PHONE:		919-578-5901

	MAIL ADDRESS:	
		STREET 1:		4721 EMPEROR BOULEVARD
		STREET 2:		SUITE 350
		CITY:			DURHAM
		STATE:			NC
		ZIP:			27703

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Marina Biotech, Inc.
		DATE OF NAME CHANGE:	20100722

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	MDRNA, Inc.
		DATE OF NAME CHANGE:	20080610

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NASTECH PHARMACEUTICAL CO INC
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>NT 10-Q
<SEQUENCE>1
<FILENAME>formnt-10q.htm
<TEXT>
Document 1 - file: formnt-10q.htm

</DOCUMENT>
</SEC-DOCUMENT>